Ravetaara Diabetics Profile
Key Indicators
- Authorised Capital ₹ 8.00 M
- Paid Up Capital ₹ 7.94 M
- Company Age 21 Year, 29 Days
- Last Filing with ROC 31 Mar 2023
- Revenue Growth -38.30%
- Profit Growth -54.67%
- Ebitda 72.06%
- Net Worth 13.90%
- Total Assets 25.29%
About Ravetaara Diabetics
Ravetaara Diabetics Private Limited (RDPL) is a Private Limited Indian Non-Government Company incorporated in India on 27 January 2004 and has a history of 21 years. Its registered office is in Kolkata, West Bengal, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 8.00 M and a paid-up capital of Rs 7.94 M, as per Ministry of Corporate Affairs (MCA) records.
Amit Agrawal, Prakash Agrawal, and Shambhu Choubey serve as directors at the Company.
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U85110WB2004PTC210457
- Company No.
210457
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Jan 2004
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Who are the key members and board of directors at Ravetaara Diabetics?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amit Agrawal  | Whole-Time Director | 30-Mar-2023 | Current |
| Prakash Agrawal | Director | 06-Dec-2006 | Current |
| Shambhu Choubey | Director | 03-May-2010 | Current |
Financial Performance of Ravetaara Diabetics.
Ravetaara Diabetics Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 38.3% decrease. The company also saw a substantial fall in profitability, with a 54.67% decrease in profit. The company's net worth Soared by an impressive increase of 13.9%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ravetaara Diabetics?
In 2023, Ravetaara Diabetics had a promoter holding of 100.00%. The company had 2 Subsidiaries and 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Indivac Healthcare Private LimitedAmit Agrawal and Shambhu Choubey are mutual person
Leopin Enterprise LlpAmit Agrawal is a mutual person
- Pace Biotech Private Limited
Amit Agrawal is a mutual person
- Gochem Speciality Chemicals Private Limited
Amit Agrawal is a mutual person
- Tripti Traders Pvt Ltd
Amit Agrawal and Shambhu Choubey are mutual person
- Solar Trading & Investment Ltd
Amit Agrawal is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ravetaara Diabetics?
Ravetaara Diabetics has a workforce of 4 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ravetaara Diabetics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ravetaara Diabetics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
